InnaVirVax's Series B Round

InnaVirVax raised a round of funding on April 29, 2014. Investors include BPI France.

InnaVirVax is a biopharmaceutical company researching and developing therapeutic and diagnostic solutions for diseases linked to the immune system. Through its research on immune dysregulations, the c…

Articles about InnaVirVax's Series B Round: